C. Begg

C. Begg, M. Berwick, 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Melanoma molecular subtypes: unifying and paradoxical results.

C. Begg, K. Conway, M. Berwick, 2010, The Journal of investigative dermatology.

Comparison of adriamycin with cyclophosphamide in patients with advanced endometrial cancer.

C. Begg, R. Hahn, J. Horton, 1978, Cancer treatment reports.

Patterns and sources of information about family melanoma risk among melanoma survivors.

C. Begg, I. Orlow, Yuelin Li, 2016, Melanoma management.

Cancer in the Elderly: Clinical and Biologic Considerations

C. Begg, J. Moorman, P. Carbone, 1985 .

Topical Hidden Genome: Discovering Latent Cancer Mutational Topics using a Bayesian Multilevel Context-learning Approach

C. Begg, Saptarshi Chakraborty, R. Shen, 2022, 2212.14567.

An Assessment of Publication Bias Using a Sample of Published Clinical Trials

Thomas A. Louis, Jesse A. Berlin, Colin B. Begg, 1989 .

A measure to aid in the interpretation of published clinical trials.

C B Begg, C. Begg, 1985, Statistics in medicine.

An assessment of estimation methods for generalized linear mixed models with binary outcomes

Mithat Gönen, Colin B Begg, Marinela Capanu, 2013, Statistics in medicine.

Defining Cancer Subtypes With Distinctive Etiologic Profiles: An Application to the Epidemiology of Melanoma

V. Seshan, C. Begg, E. Zabor, 2017, Journal of the American Statistical Association.

Assessment of diagnostic tests when disease verification is subject to selection bias.

R A Greenes, C B Begg, C. Begg, 1983, Biometrics.

On inferences from Wei's biased coin design for clinical trials

Colin B. Begg, C. Begg, 1990 .

Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies.

C. Begg, Z. F. Zhang, Zuo‐Feng Zhang, 1994, International journal of epidemiology.

Evidence for Etiologic Subtypes of Breast Cancer in the Carolina Breast Cancer Study

C. Begg, E. Zabor, M. Troester, 2019, Cancer Epidemiology, Biomarkers & Prevention.

Statistical analysis of molecular epidemiology studies employing case-series.

C B Begg, C. Begg, Z. F. Zhang, 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Properties of A Nonparametric Test for Early Comparison of Treatments in Clinical Trials in the Presence of Surrogate Endpoints

C. Begg, E. Venkatraman, 1999, Biometrics.

Associations of Cumulative Sun Exposure and Phenotypic Characteristics with Histologic Solar Elastosis

R. Millikan, S. Rosso, C. Begg, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Influence of hospital procedure volume on outcomes following surgery for colon cancer.

C. Begg, J. Warren, D. Schrag, 2000, JAMA.

A randomized study of the efficacy of consolidation therapy in adult acute nonlymphocytic leukemia.

C. Begg, J. Glick, J. Bennett, 1984, Blood.

Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.

S. Rosso, C. Begg, S. Gruber, 2014, JAMA dermatology.

Association of Melanoma-Risk Variants with Primary Melanoma Tumor Prognostic Characteristics and Melanoma-Specific Survival in the GEM Study

S. Rosso, C. Begg, S. Gruber, 2021, Current oncology.

Disease-Associated Risk Variants in ANRIL Are Associated with Tumor-Infiltrating Lymphocyte Presence in Primary Melanomas in the Population-Based GEM Study

S. Rosso, C. Begg, S. Gruber, 2021, Cancer Epidemiology, Biomarkers & Prevention.

Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.

S. Rosso, C. Begg, S. Gruber, 2015, JAMA oncology.

Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study.

S. Rosso, C. Begg, S. Gruber, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association of Incident Amelanotic Melanoma With Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma

S. Rosso, C. Begg, S. Gruber, 2017, JAMA dermatology.

Clinical trials and drug toxicity in the elderly. The experience of the eastern cooperative oncology group

C. Begg, P. Carbone, 1983, Cancer.

Blocking and Randomization to Improve Molecular Biomarker Discovery

Qin Zhou, Colin B. Begg, Jaya M. Satagopan, 2014, Clinical Cancer Research.

Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study

C. Begg, Å. Borg, L. Bernstein, 2010, Cancer Causes & Control.

Examining the common aetiology of serous ovarian cancers and basal-like breast cancers using double primaries

C. Begg, E. Zabor, S. Tworoger, 2017, British Journal of Cancer.

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

Joseph R. Bertino, Colin B. Begg, Pierre R. Band, 1980, The American journal of medicine.

A comparative clinical trial of adriamycin and 5‐fluorouracil in advanced prostatic cancer: Prognostic factors and response

C. Begg, W. Dewys, J. Khandekar, 1983, The Prostate.

Breast cancer after chest radiation therapy for childhood cancer.

C. Begg, M. Hudson, L. Robison, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Exome-Wide Pan-Cancer Analysis of Germline Variants in 8,719 Individuals Finds Little Evidence of Rare Variant Associations

C. Begg, R. Shen, Zoe Guan, 2021, Human Heredity.

Methylation of nonessential genes in cutaneous melanoma – Rule Out hypothesis

C. Begg, I. Gorlov, R. Shen, 2023, Melanoma research.

Rare germline mutations in PALB2 and breast cancer risk: A population‐based study

C. Begg, W. Foulkes, S. Tavtigian, 2012, Human mutation.

The use of hierarchical models for estimating relative risks of individual genetic variants: An application to a study of melanoma

Duncan C Thomas, Marianne Berwick, Colin B Begg, 2008, Statistics in medicine.

Assessment of rare BRCA1 and BRCA2 variants of unknown significance using hierarchical modeling

C. Begg, L. Bernstein, P. Concannon, 2011, Genetic epidemiology.

Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study

A. Børresen-Dale, C. Begg, Å. Borg, 2010, Human mutation.

Familial aggregation of melanoma risks in a large population-based sample of melanoma cases

R. Millikan, C. Begg, T. Rebbeck, 2004, Cancer Causes & Control.

Familial aggregation of melanoma risks in a large population-based sample of melanoma cases

R. Millikan, C. Begg, T. Rebbeck, 2004, Cancer Causes & Control.

Number of Nevi and Early-Life Ambient UV Exposure Are Associated with BRAF-Mutant Melanoma

R. Millikan, C. Begg, A. Hummer, 2007, Cancer Epidemiology Biomarkers & Prevention.

Contralateral breast cancers: Independent cancers or metastases?

V. Seshan, C. Begg, J. Reis-Filho, 2018, International journal of cancer.

V. Seshan, C. Begg, I. Ostrovnaya, 2012, Breast Cancer Research.

Identifying Etiologically Distinct Sub-Types of Cancer: A Demonstration Project Involving Breast Cancer

V. Seshan, C. Begg, E. Zabor, 2015, Cancer medicine.

Detecting and exploiting etiologic heterogeneity in epidemiologic studies.

C. Begg, E. Zabor, 2012, American journal of epidemiology.

A strategy for distinguishing optimal cancer subtypes

C. Begg, 2011, International journal of cancer.

Clonal relationships between lobular carcinoma in situ and other breast malignancies

V. Seshan, C. Begg, I. Ostrovnaya, 2016, Breast Cancer Research.

The interaction between vitamin D receptor polymorphisms and sun exposure around time of diagnosis influences melanoma survival

S. Rosso, C. Begg, S. Gruber, 2018, Pigment cell & melanoma research.

Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.

R. Millikan, C. Begg, T. Rebbeck, 2005, Journal of the National Cancer Institute.

Mining mutation contexts across the cancer genome to map tumor site of origin

C. Begg, R. Shen, Saptarshi Chakraborty, 2021, Nature Communications.

A metastasis or a second independent cancer? Evaluating the clonal origin of tumors using array copy number data

Irina Ostrovnaya, Irene Orlow, D. Albertson, 2010, Statistics in medicine.

Statistical Tests for Clonality

C. Begg, K. Eng, A. Hummer, 2007, Biometrics.

V. Seshan, C. Begg, I. Ostrovnaya, 2012, Breast Cancer Research.

Clonality: an R package for testing clonal relatedness of two tumors from the same patient based on their genomic profiles

Adam B. Olshen, Colin B. Begg, Irina Ostrovnaya, 2011, Bioinform..

Testing clonal relatedness of two tumors from the same patient based on their mutational profiles: update of the Clonality R package

Irina Ostrovnaya, Colin B Begg, Venkatraman E Seshan, 2019, Bioinform..

Estimating the probability of clonal relatedness of pairs of tumors in cancer patients

V. Seshan, C. Begg, I. Ostrovnaya, 2018, Biometrics.

USING SOMATIC MUTATION DATA TO TEST TUMORS FOR CLONAL RELATEDNESS.

V. Seshan, C. Begg, I. Ostrovnaya, 2015, The annals of applied statistics.

Testing tumors from different anatomic sites for clonal relatedness using somatic mutation data

V. Seshan, C. Begg, I. Ostrovnaya, 2020, Biometrics.

Testing Clonal Relatedness of Tumors Using Array Comparative Genomic Hybridization: A Statistical Challenge

C. Begg, I. Ostrovnaya, 2010, Clinical Cancer Research.

Staging of malignant pleural mesothelioma: comparison of CT and MR imaging.

C B Begg, J F Caravelli, C. Begg, 1999, AJR. American journal of roentgenology.

Who G ets A djuvant T reatment f or S tage I I a nd I II R ectal Cancer? I nsight F rom S urveillance, E pidemiology, a nd E nd Results-Medicare

C. Begg, J. Guillem, D. Schrag, 2001 .

The association of patients' socioeconomic characteristics with the length of hospital stay and hospital charges within diagnosis-related groups.

R. Stern, C. Begg, A. Epstein, 1988, The New England journal of medicine.

The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation.

C B Begg, S A Leibel, Z Fuks, 1991, International journal of radiation oncology, biology, physics.

Variations among high volume surgeons in the rate of complications after radical prostatectomy: further evidence that technique matters.

C. Begg, M. Kattan, P. Scardino, 2005, The Journal of urology.

Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population.

C. Begg, D. Schrag, P. Bach, 2005, Urology.

Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens.

Victor Reuter, Mithat Gonen, Colin B Begg, 2003, The Journal of urology.

The influence of hospital volume on survival after resection for lung cancer.

C. Begg, D. Schrag, P. Bach, 2001, The New England journal of medicine.

Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations.

C. Pui, C. Begg, N. Rothman, 2006, Journal of the National Cancer Institute.

Evaluating Cancer Epidemiologic Risk Factors Using Multiple Primary Malignancies

C. Begg, E. Imyanitov, A. Reiner, 2010, Epidemiology.

Prolonged unmaintained remission after intensive consolidation therapy in adult acute nonlymphocytic leukemia.

C. Begg, J. Bennett, J. Mazza, 1987, Cancer treatment reports.

Variation of Breast Cancer Risk Among BRCA 1 / 2 Carriers : An Investigation by the WECARE Study Group

C. Begg, J. Olsen, Å. Borg, 2009 .

Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma.

C. Begg, J. Kirkwood, A. Houghton, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I II M ulticenter R andomized T rial o f t he D artmouth Regimen V ersus D acarbazine i n P atients With M etastatic M elanoma

C. Begg, J. Kirkwood, A. Houghton, 1999 .

Pharmacokinetics of continuous-infusion high-dose thiotepa.

C. Begg, T. Shea, J. Eder, 1987, Cancer treatment reports.

The comparison of total body irradiation vs chlorambucil and prednisone for remission induction of active chronic lymphocytic leukemia: an ECOG study. Part I: total body irradiation-response and toxicity.

C. Begg, P. Rubin, J. Bennett, 1981, International journal of radiation oncology, biology, physics.

A Metastasis or a Second Independent Cancer ? Evaluating the Clonal Origin of Tumors Using Array-CGH Data

D. Albertson, A. Olshen, V. Seshan, 2017 .

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

C. Begg, P. Band, P. Lavin, 1980, The American journal of medicine.

Optimal sample size for a series of pilot trials of new agents.

C B Begg, T J Yao, P O Livingston, 1996, Biometrics.

Comparing ROC curves derived from regression models

V. Seshan, C. Begg, M. Gönen, 2013, Statistics in medicine.

The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.

C B Begg, W Foulkes, K Offit, 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes.

S. Rosso, C. Begg, S. Gruber, 2018, The Journal of investigative dermatology.

Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways.

S. Rosso, C. Begg, S. Gruber, 2016, Journal of the National Cancer Institute.

Inherited variation at MC1R and ASIP and association with melanoma‐specific survival

S. Rosso, C. Begg, T. Rebbeck, 2015, International journal of cancer.

Inherited Genetic Variants Associated with Occurrence of Multiple Primary Melanoma

S. Rosso, C. Begg, S. Gruber, 2015, Cancer Epidemiology, Biomarkers & Prevention.

MC1R genotype may modify the effect of sun exposure on melanoma risk in the GEM study

R. Millikan, S. Rosso, C. Begg, 2010, Cancer Causes & Control.

MITF E318K's effect on melanoma risk independent of, but modified by, other risk factors

S. Rosso, C. Begg, S. Gruber, 2014, Pigment cell & melanoma research.

Relationship between germline MC1R variants and BRAF-mutant melanoma in a North Carolina population-based study.

C. Begg, K. Conway, S. Edmiston, 2010, The Journal of investigative dermatology.

Prognostic factors in differentiated carcinoma of the thyroid gland.

C. Begg, E. Strong, J. Shah, 1992, American journal of surgery.

Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations.

Colin B Begg, C. Begg, P. Scardino, 2003, JAMA.

On the use of surrogate end points in randomized trials

C. Begg, D. Leung, Denis H. Y. Leung, 2000 .

DNA damage and repair capacity in patients with lung cancer: prediction of multiple primary tumors.

C. Begg, M. Kris, V. Rusch, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An efficient basket trial design

Mithat Gönen, Alexia Iasonos, Ronglai Shen, 2017, Statistics in medicine.

Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: a population-based study.

S. Rosso, C. Begg, S. Gruber, 2016, Carcinogenesis.

Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: A population-based study.

S. Rosso, C. Begg, S. Gruber, 2015, Carcinogenesis.

Inherited Melanoma Risk Variants Associated with Histopathologically Amelanotic Melanoma.

S. Rosso, C. Begg, S. Madronich, 2020, The Journal of investigative dermatology.

Marrow transplantation for acute nonlymphoblastic leukemia.

C. Begg, J. Bennett, P. Cassileth, 1980, The New England journal of medicine.

ROC curve regression analysis: the use of ordinal regression models for diagnostic test assessment.

M. Weinstein, C. Begg, A. Tosteson, 1994, Environmental health perspectives.

Inherited Variation at MC1R and Histological Characteristics of Primary Melanoma

S. Rosso, C. Begg, T. Rebbeck, 2015, PloS one.

The Prevalence of CDKN2A Germ-Line Mutations and Relative Risk for Cutaneous Malignant Melanoma: An International Population-Based Study

R. Millikan, C. Begg, T. Rebbeck, 2006, Cancer Epidemiology Biomarkers & Prevention.

The Prevalence of CDKN 2 A GermLine Mutations and Relative Risk for Cutaneous Malignant Melanoma : An International Population-Based Study

R. Millikan, C. Begg, T. Rebbeck, 2006 .

High-dose ifosfamide with mesna uroprotection: a phase I study.

C. Begg, T. Shea, J. Eder, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparing tumour staging and grading systems: a case study and a review of the issues, using thymoma as a model.

C. Begg, E. Venkatraman, J. Rosai, 2000, Statistics in medicine.

Clinicopathologic Features of Incident and Subsequent Tumors in Patients with Multiple Primary Cutaneous Melanomas

S. Rosso, C. Begg, S. Gruber, 2012, Annals of Surgical Oncology.

Kin‐cohort evaluation of relative risks of genetic variants

C. Begg, C. Saunders, 2003, Genetic epidemiology.

VM-26, a new anticancer drug with effectiveness in malignant lymphoma: an Eastern Cooperative Oncology Group Study (EST 1474).

C. Begg, J. Glick, J. Bennett, 1979, Cancer treatment reports.

Eastern Cooperative Oncology Group study of the cytochemistry of adult acute myeloid leukemia by correlation of subtypes with response and survival.

C. Begg, J. Bennett, 1981, Cancer research.

Are the elderly predisposed to toxicity from cancer chemotherapy? An investigation using data from the Eastern Cooperative Oncology Group.

C. Begg, J. Cohen, J. Ellerton, 1980, Cancer clinical trials.

High peripheral blast count in adult acute myelogenous leukemia is a primary risk factor for CNS leukemia.

C. Begg, J. Bennett, P. Cassileth, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A critical comparison of allogeneic bone marrow transplantation and conventional chemotherapy as treatment for acute nonlymphocytic leukemia.

C. Begg, M. Oken, J. Bennett, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cautionary Note on Using Cross-Validation for Molecular Classification.

Huei-Chung Huang, Li-Xuan Qin, Colin B Begg, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of renal carcinoma: a phase III randomized trial of oral medroxyprogesterone (Provera), hydroxyurea, and nafoxidine.

C. Begg, J. Horton, L. Stolbach, 1981, Cancer treatment reports.

Phase II study of vinblastine-CCNU, triazinate, and dactinomycin in advanced renal cell cancer.

C. Begg, R. Hahn, T. Davis, 1981, Cancer treatment reports.

Predicting Cancer Risk from Germline Whole-exome Sequencing Data Using a Novel Context-based Variant Aggregation Approach

C. Begg, R. Shen, Zoe Guan, 2023, Cancer research communications.

Computed Tomography Screening for Lung Cancer—Reply

C. Begg, S. Swensen, J. Jett, 2007 .

Suspended judgment. Significance tests of covariate imbalance in clinical trials.

C B Begg, C. Begg, 1990, Controlled clinical trials.

Random Effects Models for Combining Results from Controlled and Uncontrolled Studies in a Meta-Analysis

Colin B. Begg, C. Begg, Zhaohai Li, 1994 .

In Defense of P Values

C. Begg, 2020, JNCI cancer spectrum.

Systematic reviews of diagnostic accuracy studies require study by study examination: first for heterogeneity, and then for sources of heterogeneity.

Colin B Begg, C. Begg, 2005, Journal of clinical epidemiology.

Reporting Participation in Case-Control Studies

C. Begg, N. Weiss, S. Olson, 2002, Epidemiology.

Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer

C. Begg, Å. Borg, L. Bernstein, 2010, Breast Cancer Research and Treatment.

Sun protection and skin self‐examination in melanoma survivors

C. Begg, S. Oliveria, A. Hummer, 2009, Psycho-oncology.

Comparison of community pathologists with expert dermatopathologists evaluating Breslow thickness and histopathologic subtype in a large international population-based study of melanoma

S. Rosso, C. Begg, S. Madronich, 2021, JAAD international.

Functional melanoma‐risk variant IRF4 rs12203592 associated with Breslow thickness: a pooled international study of primary melanomas

S. Rosso, C. Begg, H. Anton-Culver, 2017, The British journal of dermatology.

Association of Known Melanoma Risk Factors with Primary Melanoma of the Scalp and Neck

S. Rosso, C. Begg, S. Gruber, 2020, Cancer Epidemiology, Biomarkers & Prevention.

Variants in autophagy‐related genes and clinical characteristics in melanoma: a population‐based study

S. Rosso, C. Begg, S. Madronich, 2016, Cancer medicine.

impact of Hospital Volume on Operative Mortality for Major Cancer Surgery

C. Begg, M. Brennan, L. Cramer, 1999 .

Year Paper A Hybrid Bayesian Laplacian Approach for Generalized Linear Mixed Models

C. Begg, M. Gonen, 2017 .

A Hybrid Bayesian Laplacian Approach for Generalized Linear Mixed Models

Colin B. Begg, Mithat Gonen, Marinela Capanu, 2011 .

Resurrecting treatment histories of dead patients: a study design that should be laid to rest.

C. Begg, D. Schrag, P. Bach, 2004, JAMA.

Testing for Fetal Pulmonary Maturity

C B Begg, C. Begg, P. Doubilet, 1990, Medical decision making : an international journal of the Society for Medical Decision Making.

A General Regression Methodology for ROC Curve Estimation

C B Begg, C. Begg, A N Tosteson, 1988, Medical decision making : an international journal of the Society for Medical Decision Making.

Response to ROC Steady

J A Hanley, C B Begg, J. Hanley, 1987, Medical decision making : an international journal of the Society for Medical Decision Making.

A model for incorporating historical controls into a meta-analysis.

C B Begg, L Pilote, C. Begg, 1991, Biometrics.

Properties of analysis methods that account for clustering in volume–outcome studies when the primary predictor is cluster size

Katherine S Panageas, Colin B Begg, Deborah Schrag, 2007, Statistics in medicine.

The mammography controversy.

C. Begg, 2002, The oncologist.

The use of ambulatory testing in prepaid and fee-for-service group practices. Relation to perceived profitability.

C B Begg, B J McNeil, A M Epstein, 1986, The New England journal of medicine.

The effect of age on the care of women with breast cancer in community hospitals.

C. Begg, L. Ford, P. Diehr, 1987, Journal of gerontology.

Timing of radiotherapy in the treatment of early-stage breast cancer.

C. Begg, L. Norton, B. McCormick, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Measuring Complications of Cancer Treatment Using the SEER-Medicare Data

Colin B Begg, Craig C Earle, C. Earle, 2002, Medical care.

Patient-Oriented Performance Measures of Diagnostic Tests

R A Greenes, J A Swets, C B Begg, 1984, Medical decision making : an international journal of the Society for Medical Decision Making.

Patient-Oriented Performance Measures

R A Greenes, C B Begg, K C Cain, 1984, Medical decision making : an international journal of the Society for Medical Decision Making.

Patient-Oriented Performance Measures of Diagnostic Tests

R A Greenes, C B Begg, K C Cain, 1984, Medical decision making : an international journal of the Society for Medical Decision Making.

Physician visits prior to treatment for clinically localized prostate cancer.

C. Begg, E. Elkin, T. Jang, 2010, Archives of internal medicine.

The search for cancer risk factors: when can we stop looking?

C B Begg, C. Begg, 2001, American journal of public health.

Methodology for case-control studies with prevalent cases

R. Gray, C. Begg, 1987 .

Diagnostic Tests, Evaluation of†

Colin B. Begg, C. Begg, 2014 .

Diagnostic Tests, Evaluation of

Colin B. Begg, C. Begg, 2005 .

Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer: results of a phase II study.

C. Begg, P. Russo, V. Reuter, 1997, British journal of urology.

The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results.

C. Begg, P. Russo, V. Reuter, 1997, Urology.

Using the “Hidden” genome to improve classification of cancer types

Ronglai Shen, Colin B. Begg, Saptarshi Chakraborty, 2020, Biometrics.

Separate Estimation of Primary and Secondary Cancer Preventive Impact: Analysis of a Case-Control Study of Skin Self-Examination and Melanoma

C. Begg, M. Berwick, Ying Huang, 1996 .

Disenrollment from Medicare managed care among beneficiaries with and without a cancer diagnosis.

C. Begg, E. Elkin, M. Gonen, 2008, Journal of the National Cancer Institute.

Diverse prognosis in metastatic breast cancer: Who should be offered alternative initial therapies?

C. Begg, R. Mick, A. Korzun, 2005, Breast Cancer Research and Treatment.

Testing the incremental predictive accuracy of new markers

Mithat Gonen, Colin B Begg, Venkatraman E Seshan, 2013, Clinical trials.

A distribution-free procedure for comparing receiver operating characteristic curves from a paired experiment

E. S. Venkatraman, Colin B. Begg, C. Begg, 1996 .

Statistical methods in medical diagnosis.

C B Begg, C. Begg, 1986, Critical reviews in medical informatics.

Clinical Trial Participation Among Older Adult Medicare Fee-for-Service Beneficiaries With Cancer.

C. Begg, Gregory Riely, P. Sabbatini, 2022, JAMA oncology.

Sex-Specific Associations of MDM2 and MDM4 Variants with Risk of Multiple Primary Melanomas and Melanoma Survival in Non-Hispanic Whites

S. Rosso, C. Begg, H. Anton-Culver, 2023, Cancers.

Marketing Drugs Too Early in Testing

D. DeMets, R. Califf, C. Begg, 2006, Science.

New insights into the risk of breast cancer in childhood cancer survivors treated with chest radiation: A report from the Childhood Cancer Survivor Study (CCSS) and the Women's Environmental Cancer and Radiation Epidemiology (WECARE) Study.

C. Begg, M. Hudson, L. Robison, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A risk prediction model for the development of subsequent primary melanoma in a population‐based cohort

C. Begg, L. Haydu, I. Orlow, 2020, The British journal of dermatology.

ociations of Cumulative Sun Exposure and Phenotypic B & P racteristics with Histologic Solar Elastosis

R. Millikan, S. Rosso, R. Wilcox, 2010 .

Evaluation of bone marrow toxic reaction in patients treated with allopurinol.

C. Begg, J. Glick, J. Bennett, 1982, JAMA.

Attribution of deaths following cancer treatment.

Colin B Begg, Deborah Schrag, C. Begg, 2002, Journal of the National Cancer Institute.

Development and Validation of a Breast Cancer Risk Prediction Model for Childhood Cancer Survivors Treated With Chest Radiation: A Report From the Childhood Cancer Survivor Study and the Dutch Hodgkin Late Effects and LATER Cohorts

M. Pike, C. Begg, C. Ronckers, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Participation of community hospitals in clinical trials: analysis of five years of experience in the Eastern Cooperative Oncology Group.

C. Begg, M. Zelen, P. Carbone, 1982, The New England journal of medicine.

Meta-analysis methods for diagnostic accuracy.

Colin B Begg, C. Begg, 2008, Journal of clinical epidemiology.

Construction of Receiver Operating Characteristic Curves when Disease Verification Is Subject to Selection Bias

R A Greenes, C B Begg, R Gray, 1984, Medical decision making : an international journal of the Society for Medical Decision Making.

Methodological issues in studies of the treatment, diagnosis, and etiology of prostate cancer.

C. Begg, 1994, Seminars in oncology.

Erratum: Clinicopathologic features of incident and subsequent tumors in patients with multiple primary cutaneous melanomas (ann surg oncol (2012) 19 (1024-1033) DOI: 10.1245/S10434-011-2058-8)

S. Rosso, C. Begg, S. Gruber, 2013 .

The effects of physicians' training and personality on test ordering for ambulatory patients.

C B Begg, B J McNeil, A M Epstein, 1984, American journal of public health.

The participation of community hospitals in cancer clinical trials: results and impact of the Eastern Cooperative Oncology Group Program.

C. Begg, M. Zelen, P. Carbone, 1983, Progress in clinical and biological research.

A comparison of statistical methods for the study of etiologic heterogeneity

C. Begg, E. Zabor, 2017, Statistics in medicine.

Comments and response on the USPSTF recommendation on screening for breast cancer.

C. Begg, 2010, Annals of internal medicine.

Methodology for the Differential Diagnosis of a Complex Data Set

C B Begg, B J McNeil, B. McNeil, 1983, Medical decision making : an international journal of the Society for Medical Decision Making.

“Right to Try” laws

C. Begg, J. Neaton, KyungMann Kim, 2014, Clinical trials.

The influence of uninterpretability on the assessment of diagnostic tests.

R A Greenes, C B Begg, C. Begg, 1986, Journal of chronic diseases.

An EM algorithm to improve the estimation of the probability of clonal relatedness of pairs of tumors in cancer patients

V. Seshan, C. Begg, I. Ostrovnaya, 2019, BMC Bioinformatics.

State of the art in comparative cancer clinical trials

C. Begg, M. Zelen, S. Pocock, 1987, Cancer.

Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study

Matthew R. Schwartz, Tim K. Lee, V. Seshan, 2022, Pigment cell & melanoma research.

One statistical test is sufficient for assessing new predictive markers

C. Begg, A. Vickers, A. Cronin, 2011, BMC Medical Research Methodology.

Pathway Alterations in Stage II/III Primary Melanoma.

V. Seshan, C. Begg, E. Hernando-Monge, 2023, JCO Precision Oncology.

Publication bias and dissemination of clinical research.

C. Begg, J. Berlin, C. Begg, 1989, Journal of the National Cancer Institute.

Screening for cutaneous melanoma by skin self-examination.

C. Begg, M. Berwick, R. Barnhill, 1996, Journal of the National Cancer Institute.

Computed Tomography Screening and Lung Cancer Outcomes

C. Begg, S. Swensen, J. Jett, 2008 .

Publication Bias in Meta-Analysis: A Bayesian Data-Augmentation Approach to Account for Issues Exempli(cid:12)ed in the Passive Smoking Debate

R. Tweedie, A. Dobson, G. Givens, 1997 .

Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study.

R. Millikan, C. Begg, T. Rebbeck, 2006, Carcinogenesis.

A comparison of methods to detect publication bias in meta‐analysis by P. Macaskill, S. D. Walter and L. Irwig, Statistics in Medicine, 2001; 20:641–654

Colin B Begg, C. Begg, 2002, Statistics in medicine.

Assessment of Diagnostic Technologies: Methodology for Unbiased Estimation from Samples of Selectively Verified Patients

R A Greenes, C B Begg, C. Begg, 1985, Investigative radiology.

Experimental design of medical imaging trials. Issues and options.

C. Begg, 1989, Investigative radiology.

Letter to the Editor of Biometrics

C. Begg, 2007, Biometrics.

Subsampling based variable selection for generalized linear models

C. Begg, M. Gönen, M. Capanu, 2023, Comput. Stat. Data Anal..

A Method for Evaluating the Impact of Individual Haplotypes on Disease Incidence in Molecular Epidemiology Studies

C. Begg, E. Venkatraman, N. Mitra, 2004, Statistical applications in genetics and molecular biology.

Planning controlled clinical trials

L. Holmberg, T. Wilt, C. Begg, 1997 .

Association of IRF4 single‐nucleotide polymorphism rs12203592 with melanoma‐specific survival

S. Rosso, C. Begg, S. Gruber, 2020, The British journal of dermatology.

Justifying the choice of endpoints for clinical trials.

C. Begg, 2013, Journal of the National Cancer Institute.

Planning controlled clinical trials. Prostatic cancer.

L. Holmberg, T. Wilt, C. Begg, 1997, Urology.

Sun exposure, vitamin D receptor polymorphisms FokI and BsmI and risk of multiple primary melanoma.

R. Millikan, S. Rosso, C. Begg, 2011, Cancer epidemiology.

Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations.

C. Pui, C. Begg, N. Rothman, 2006, Journal of the National Cancer Institute.

Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study

A. Børresen-Dale, C. Begg, Å. Borg, 2010, Human mutation.

The first international workshop on the role and impact of mathematics in medicine: A collective account

Jean Clairambault, Eva K. Lee, Colin B Begg, 2011 .

Estimating the empirical Lorenz curve and Gini coefficient in the presence of error with nested data

V. Seshan, C. Begg, C. Moskowitz, 2008, Statistics in medicine.

THE THIRD INTERNATIONAL MOLECULAR PATHOLOGICAL EPIDEMIOLOGY (MPE) MEETING

Andrew H. Beck, C. Huttenhower, John Quackenbush, 2016 .

Bone marrow transplantation versus chemotherapy in acute non-lymphocytic leukemia: a meta-analytic review.

C. Begg, L. Pilote, P. Mcglave, 1989, European journal of cancer & clinical oncology.

Ruminations on the intent-to-treat principle.

C. Begg, 2000, Controlled Clinical Trials.

Variation of breast cancer risk among BRCA1/2 carriers.

C. Begg, J. Olsen, Å. Borg, 2008, JAMA.

Chemotherapy for advanced germinal cell neoplasms: preliminary report of an Eastern Cooperative Oncology Group Study.

C. Begg, R. Hahn, W. Dewys, 1979, Cancer treatment reports.